Fundraising Fox

EndLyz Therapeutics

Boston, US · Founded 2021 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

JC
Justian Craig FoxDirector
DL
Donmienne LeungDirector
LB
Laurence BarkerDirector
TE
Timothy EdwardsDirector
JW
Joanna WolakExecutive Officer, Director
JB
Jonathan BehrDirector
JG
John GustofsonDirector
DC
Damian CrowtherDirector
ZK
Zaven KaprielianExecutive Officer, Director

Investors · 1

Oxford Science EnterprisesOxford · $63.5K – $31.8M

Reported raises · per SEC filings

Form D private placements
▶$17.3MraisedMay 2026 · 7 investors · Other
Rule 506(b)
Funding drug development to help recycling in cells | Parkinson's UKparkinsons.org.uk · Apr 2026
Officers, directors & promoters on the filing
  • Justian Craig FoxDirector
  • Donmienne LeungDirector
  • Laurence BarkerDirector
  • Timothy EdwardsDirector
  • Joanna WolakExecutive Officer, Director
Offering amount
$19.7M
Amount sold
$17.3M
First sale
Mar 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.3MraisedJul 2021 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan BehrDirector
  • Joanna WolakExecutive Officer
  • John GustofsonDirector
  • Damian CrowtherDirector
  • Zaven KaprielianExecutive Officer, Director
Offering amount
$6.5M
Amount sold
$3.3M
First sale
Jul 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news